{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:16:57Z","timestamp":1783523817859,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2021A1515010100"],"award-info":[{"award-number":["2021A1515010100"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00790-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:03:07Z","timestamp":1778490187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ELOVL1 promotes the progression of intrahepatic cholangiocarcinoma by enhancing endoplasmic reticulum stress and the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Weigen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayuanzi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"161","key":"790_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, de Martel C, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J cancer (Oxford England: 1990). 2022;161(161):108\u201318. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.023.","journal-title":"Eur J cancer (Oxford England: 1990)"},{"issue":"6","key":"790_CR2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77(6):1690\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.022.","journal-title":"J Hepatol"},{"issue":"1","key":"790_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"European Association for the Study of the L","year":"2023","unstructured":"European Association for the Study of the L. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79(1):181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010.","journal-title":"J Hepatol"},{"issue":"7","key":"790_CR4","doi-asserted-by":"publisher","first-page":"e0743","DOI":"10.1097\/HC9.0000000000000743","volume":"9","author":"R Gujarathi","year":"2025","unstructured":"Gujarathi R, Peshin S, Zhang X, et al. Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel. Hepatol Commun. 2025;9(7):e0743. https:\/\/doi.org\/10.1097\/HC9.0000000000000743.","journal-title":"Hepatol Commun"},{"issue":"3","key":"790_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2022.01.004","volume":"77","author":"AK Gravely","year":"2022","unstructured":"Gravely AK, Vibert E, Sapisochin G. Surgical treatment of intrahepatic cholangiocarcinoma. J Hepatol. 2022;77(3):865\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2022.01.004.","journal-title":"J Hepatol"},{"issue":"2","key":"790_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, et al. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):364\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.020.","journal-title":"J Hepatol"},{"issue":"6","key":"790_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","volume":"5","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Javle MM, Xiao L, et al. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanc ed Biliary Tract Cancers: A Phase 2 Clinical Trial. JAMA Oncol. 2019;5(6):824\u201330. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0270.","journal-title":"JAMA Oncol"},{"issue":"2","key":"790_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, et al. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353\u201363. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.009.","journal-title":"J Hepatol"},{"issue":"3","key":"790_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.plipres.2006.01.004","volume":"45","author":"A Jakobsson","year":"2006","unstructured":"Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res. 2006;45(3):237\u201349. https:\/\/doi.org\/10.1016\/j.plipres.2006.01.004.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"790_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/emmm.201000061","volume":"2","author":"R Ofman","year":"2010","unstructured":"Ofman R, Dijkstra IME, van Roermund CWT, et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med. 2010;2(3):90\u20137. https:\/\/doi.org\/10.1002\/emmm.201000061.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"790_CR11","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1038\/s41598-021-85603-w","volume":"11","author":"K Hama","year":"2021","unstructured":"Hama K, Fujiwara Y, Hayama T, et al. Very long-chain fatty acids are accumulated in triacylglycerol and nonesterified forms in colorectal cancer tissues. Sci Rep. 2021;11(1):6163. https:\/\/doi.org\/10.1038\/s41598-021-85603-w.","journal-title":"Sci Rep"},{"issue":"15","key":"790_CR12","doi-asserted-by":"publisher","first-page":"e34961","DOI":"10.1016\/j.heliyon.2024.e34961","volume":"10","author":"L Qin","year":"2024","unstructured":"Qin L, Song C-Z, Yuan F-Y, et al. ELOVL1 is upregulated and promotes tumor growth in hepatocellular carcinoma through regulating PI3K-AKT-mTOR signaling. Heliyon. 2024;10(15):e34961. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34961.","journal-title":"Heliyon"},{"issue":"9","key":"790_CR13","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-10-3894","volume":"71","author":"M Hilvo","year":"2011","unstructured":"Hilvo M, Denkert C, Lehtinen L, et al. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res. 2011;71(9):3236\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3894.","journal-title":"Cancer Res"},{"issue":"3","key":"790_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s42255-025-01233-w","volume":"7","author":"S Pretto","year":"2025","unstructured":"Pretto S, Yu Q, Bourdely P, et al. A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8\u2009+\u2009T cell fitness in solid tumours. Nat metabolism. 2025;7(3):508\u201330. https:\/\/doi.org\/10.1038\/s42255-025-01233-w.","journal-title":"Nat metabolism"},{"issue":"1","key":"790_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi Y, Oyang L, et al. Endoplasmic reticulum stress-a key guardian in cancer. Cell death discovery. 2024;10(1):343. https:\/\/doi.org\/10.1038\/s41420-024-02110-3.","journal-title":"Cell death discovery"},{"issue":"2","key":"790_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71\u201388. https:\/\/doi.org\/10.1038\/s41568-020-00312-2.","journal-title":"Nat Rev Cancer"},{"key":"790_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","volume":"80","author":"D Tewari","year":"2022","unstructured":"Tewari D, Patni P, Bishayee A, et al. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. Sem Cancer Biol. 2022;80:1\u201317. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.008.","journal-title":"Sem Cancer Biol"},{"issue":"24","key":"790_CR18","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1021\/acs.jmedchem.2c01070","volume":"65","author":"J Huang","year":"2022","unstructured":"Huang J, Chen L, Wu J, et al. Targeting the PI3K\/AKT\/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions. J Med Chem. 2022;65(24):16033\u201361. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01070.","journal-title":"J Med Chem"},{"issue":"2","key":"790_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"790_CR20","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1158\/0008-5472.CAN-22-3032","volume":"83","author":"S Mafi","year":"2023","unstructured":"Mafi S, Ahmadi E, Meehan E, et al. The mTOR Signaling Pathway Interacts with the ER Stress Response and t he Unfolded Protein Response in Cancer. Cancer Res. 2023;83(15):2450\u201360. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3032.","journal-title":"Cancer Res"},{"issue":"10","key":"790_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul A, Cutcutache I, Yong CH, et al. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Cancer Discov. 2017;7(10):1116\u201335. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0368.","journal-title":"Cancer Discov"},{"issue":"4","key":"790_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen JB, Spee B, Blechacz BR, et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012;142(4):1021\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.005.","journal-title":"Gastroenterology"},{"issue":"6","key":"790_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variatio n in high-throughput experiments. Bioinf (Oxford England). 2012;28(6):882\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/bts034.","journal-title":"Bioinf (Oxford England)"},{"issue":"1","key":"790_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, et al. Curr protocols Bioinf. 2016;54(13031\u2013). https:\/\/doi.org\/10.1002\/cpbi.5. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses.","journal-title":"Curr. Protoc. Bioinform."},{"issue":"5","key":"790_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"790_CR26","doi-asserted-by":"publisher","unstructured":"Subramanian A, Tamayo P, Mootha VK et al. ,. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States o f America 2005;102(43):15545\u201315550.https:\/\/doi.org\/10.1073\/pnas.0506580102","DOI":"10.1073\/pnas.0506580102"},{"key":"790_CR27","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14(7). https:\/\/doi.org\/10.1186\/1471-2105-14-7.","DOI":"10.1186\/1471-2105-14-7"},{"key":"790_CR28","doi-asserted-by":"publisher","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"790_CR29","doi-asserted-by":"publisher","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(2612). https:\/\/doi.org\/10.1038\/ncomms3612.","DOI":"10.1038\/ncomms3612"},{"issue":"D1","key":"790_CR30","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"key":"790_CR31","doi-asserted-by":"publisher","unstructured":"Nohara Y, Matsumoto K, Soejima H, et al. Explanation of machine learning models using shapley additive explanat ion and application for real data in hospital. Comput Methods Programs Biomed. 2022;214(106584). https:\/\/doi.org\/10.1016\/j.cmpb.2021.106584.","DOI":"10.1016\/j.cmpb.2021.106584"},{"issue":"1","key":"790_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41467-017-02465-5","volume":"9","author":"S-I Lee","year":"2018","unstructured":"Lee S-I, Celik S, Logsdon BA, et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun. 2018;9(1):42. https:\/\/doi.org\/10.1038\/s41467-017-02465-5.","journal-title":"Nat Commun"},{"key":"790_CR33","doi-asserted-by":"publisher","unstructured":"Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12(77). https:\/\/doi.org\/10.1186\/1471-2105-12-77.","DOI":"10.1186\/1471-2105-12-77"},{"issue":"1","key":"790_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 2022;40(1):70\u201387. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.006.","journal-title":"Cancer Cell"},{"key":"790_CR35","doi-asserted-by":"crossref","unstructured":"Zhang J, Jin Z. cutoff: Seek the Significant Cutoff Value. vol. R package version 1.3; 2019.","DOI":"10.32614\/CRAN.package.cutoff"},{"issue":"Database issue","key":"790_CR36","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955\u2013961. https:\/\/doi.org\/10.1093\/nar\/gks1111.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"790_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12885-017-3554-4","volume":"17","author":"Y Yamashita","year":"2017","unstructured":"Yamashita Y, Nishiumi S, Kono S, et al. Differences in elongation of very long chain fatty acids and fatty aci d metabolism between triple-negative and hormone receptor-positive breast cancer. BMC Cancer. 2017;17(1):589. https:\/\/doi.org\/10.1186\/s12885-017-3554-4.","journal-title":"BMC Cancer"},{"issue":"7","key":"790_CR38","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3390\/ijms26073322","volume":"26","author":"Y Razghonova","year":"2025","unstructured":"Razghonova Y, Mika A, Czapiewska M, et al. Endometrial Cancer Is Associated with Altered Metabolism and Composition of Fatty Acids. Int J Mol Sci. 2025;26(7):3322. https:\/\/doi.org\/10.3390\/ijms26073322.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"790_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017.","journal-title":"Cell"},{"issue":"17","key":"790_CR40","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"JSL Yu","year":"2016","unstructured":"Yu JSL, Cui W. Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development. 2016;143(17):3050\u201360. https:\/\/doi.org\/10.1242\/dev.137075.","journal-title":"Development"},{"issue":"4","key":"790_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.soc.2013.06.008","volume":"22","author":"B Hassan","year":"2013","unstructured":"Hassan B, Akcakanat A, Holder AM, et al. Targeting the PI3-kinase\/Akt\/mTOR signaling pathway. Surg Oncol Clin N Am. 2013;22(4):641\u201364. https:\/\/doi.org\/10.1016\/j.soc.2013.06.008.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"790_CR42","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/ijms22041743","volume":"22","author":"NV Popova","year":"2021","unstructured":"Popova NV, J\u00fccker M. The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int J Mol Sci. 2021;22(4):1743. https:\/\/doi.org\/10.3390\/ijms22041743.","journal-title":"Int J Mol Sci"},{"key":"790_CR43","doi-asserted-by":"publisher","unstructured":"Ohno Y, Suto S, Yamanaka M et al. ,. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proceedings of the National Academy of Sciences of the United States o f America 2010;107(43):18439\u201318444.https:\/\/doi.org\/10.1073\/pnas.1005572107","DOI":"10.1073\/pnas.1005572107"},{"issue":"1","key":"790_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35036052","volume":"1","author":"K Simons","year":"2000","unstructured":"Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1(1):31\u20139. https:\/\/doi.org\/10.1038\/35036052.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"790_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1194\/jlr.TR119000439","volume":"61","author":"F Mollinedo","year":"2020","unstructured":"Mollinedo F, Gajate C. Lipid rafts as signaling hubs in cancer cell survival\/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts. J Lipid Res. 2020;61(5):611\u201335. https:\/\/doi.org\/10.1194\/jlr.TR119000439.","journal-title":"J Lipid Res"},{"issue":"5","key":"790_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tcb.2012.02.006","volume":"22","author":"C Appenzeller-Herzog","year":"2012","unstructured":"Appenzeller-Herzog C, Hall MN. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 2012;22(5):274\u201382. https:\/\/doi.org\/10.1016\/j.tcb.2012.02.006.","journal-title":"Trends Cell Biol"},{"issue":"9","key":"790_CR47","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nchembio.103","volume":"4","author":"R Lasserre","year":"2008","unstructured":"Lasserre R, Guo X-J, Conchonaud F, et al. Raft nanodomains contribute to Akt\/PKB plasma membrane recruitment and activation. Nat Chem Biol. 2008;4(9):538\u201347. https:\/\/doi.org\/10.1038\/nchembio.103.","journal-title":"Nat Chem Biol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00790-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:43:59Z","timestamp":1783521839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00790-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00790-8","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study. The use of human tissues was approved by the Institutional Ethics Committee for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-sen University (Approval No.: [2020] 453; Date of Approval: Sep 23, 2020), and the study was conducted in accordance with the principles outlined in the Declaration of Helsinki. All animal experiments were conducted in accordance with the institutional guidelines and were approved by the Institutional Animal Care and Use Committee of Guangzhou Lingfu Top Biotech Co., Ltd. (Approval No.: LFTOP-IACUC-2025-0061; Date of Approval: January 8, 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have obtained informed consent for publication from all individuals involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}